Fact CheckerSign in

NCT07184814Recruiting

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

Source: ClinicalTrials.gov · Last updated 22 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).

Status (registry)
Recruiting
Study type
Observational
Enrollment
150 (estimated)
First submitted
10 Sept 2025
Start date
1 Jan 2016
Primary completion date
31 Dec 2026
Lead sponsor
China-Japan Friendship Hospital
NCT number
NCT07184814

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 1 Jan 2016 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with PAI caused by non-TAK diseases such as other types of vasculitis, fibrosing mediastinitis, pulmonary artery sarcoma, pulmonary sarcoidosis or chronic thromboembolic pulmonary hypertension

Who the study is looking for

  • Hospitalized between Jan 1, 2016 and Dec 31, 2026
  • Diagnosed with TAK according to the modified Ishikawa criteria and/or 1990 American College of Rheumatology criteria and/or 2022 ACR/EULAR criteria
  • Diagnosed with pulmonary artery involvement using computed tomography pulmonary angiography or transcatheter pulmonary angiography
  • Patients without aortic or primary branch involvement who nonetheless exhibited both clinical features and computed tomography-confirmed evidence of pulmonary artery involvement (PAI), after exclusion of other diseases causing pulmonary artery stenosis or occlusion

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
China-Japan Friendship Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.